Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning

Behavioural Brain Research

Volumn 309, Issue , 2016, Pages 1-8

  Xue, Fen ^a   Huang, Jin wen ^b   Ding, Pei yan ^b   Zang, Hong gang ^b   Kou, Zhi jian ^b   Li, Ting ^b   Fan, Juan ^c   Peng, Zheng wu ^a   Yan, Wen jun ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

HBO PC; MCAO; Nrf2; Oxidative stress; Sirt1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HEME OXYGENASE 1; MALONALDEHYDE; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; NFE2L2 PROTEIN, RAT; SIRT1 PROTEIN, RAT; SMALL INTERFERING RNA; SOD1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COGNITION; CONTROLLED STUDY; DOWN REGULATION; HYPERBARIC OXYGEN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; DISEASE MODEL; GENETICS; HYPERBARIC OXYGEN THERAPY; ISCHEMIC PRECONDITIONING; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HYPERBARIC OXYGENATION; ISCHEMIC PRECONDITIONING; MALONDIALDEHYDE; NEUROPROTECTION; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; SUPEROXIDE DISMUTASE-1;

EID: 84964510048     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.04.045     Document Type: Article

References (65)

1. Russo T., Felzani G., Marini C. Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use. J. Aging Res. 2011, 2011:108785.
2. Hacke W., Kaste M., Bluhmki E., Brozman M., Davalos A., Guidetti D., et al. Thrombolysis with alteplase 3-4.5 h after acute ischemic stroke. N. Engl. J. Med. 2008, 359:1317-1329.
3. Zhang B., Sun X.J., Ju C.H. Thrombolysis with alteplase 4.5-6 h after acute ischemic stroke. Eur. Neurol. 2011, 65:170-174.
4. Jin X., Liu J., Liu W. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis. Curr. Neurovasc. Res. 2014, 11:254-262.
5. Donnan G.A., Davis S.M., Parsons M.W., Ma H., Dewey H.M., Howells D.W. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat. Rev. Neurol. 2011, 7:400-409.
6. Yang Z.J., Xie Y., Bosco G.M., Chen C., Camporesi E.M. Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release. Eur. J. Appl. Physiol. 2010, 108:513-522.
7. Sun L., Strelow H., Mies G., Veltkamp R. Oxygen therapy improves energy metabolism in focal cerebral ischemia. Brain Res. 2011, 1415:103-108.
8. Acka G., Sen A., Canakci Z., Yildiz S., Akin A., Uzun G., et al. Effect of combined therapy with hyperbaric oxygen and antioxidant on infarct volume after permanent focal cerebral ischemia. Physiol. Res. 2007, 56:369-373.
9. Mu J., Ostrowski R.P., Soejima Y., Rolland W.B., Krafft P.R., Tang J., et al. Delayed hyperbaric oxygen therapy induces cell proliferation through stabilization of cAMP responsive element binding protein in the rat model of MCAo-induced ischemic brain injury. Neurobiol. Dis. 2013, 51:133-143.
10. Bian H., Hu Q., Liang X., Chen D., Li B., Tang J., et al. Hyperbaric oxygen preconditioning attenuates hemorrhagic transformation through increasing PPARgamma in hyperglycemic MCAO rats. Exp. Neurol. 2015, 265:22-29.
11. Soejima Y., Hu Q., Krafft P.R., Fujii M., Tang J., Zhang J.H. Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats. Exp. Neurol. 2013, 247:737-743.
12. Xiong L., Zhu Z., Dong H., Hu W., Hou L., Chen S. Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model. Chin. Med. J. Engl. 2000, 113:836-839.
13. Yan W., Zhang H., Bai X., Lu Y., Dong H., Xiong L. Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats. Brain Res. 2011, 1402:109-121.
14. Gu G.J., Li Y.P., Peng Z.Y., Xu J.J., Kang Z.M., Xu W.G., et al. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. J. Appl. Physiol. 2008, 104:1185-1191.
15. Ostrowski R.P., Jadhav V., Chen W., Zhang J.H. Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen. Acta Neurochir. Suppl. 2010, 106:47-49.
16. Li Q., Li J., Zhang L., Wang B., Xiong L. Preconditioning with hyperbaric oxygen induces tolerance against oxidative injury via increased expression of heme oxygenase-1 in primary cultured spinal cord neurons. Life Sci. 2007, 80:1087-1093.
17. Nie H., Xiong L., Lao N., Chen S., Xu N., Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J. Cereb. Blood Flow Metab. 2006, 26:666-674.
18. Chang H.C., Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 2014, 25:138-145.
19. Yan W., Fang Z., Yang Q., Dong H., Lu Y., Lei C., et al. SirT1 mediates hyperbaric oxygen preconditioning-induced ischemic tolerance in rat brain. J. Cereb. Blood Flow Metab. 2013, 33:396-406.
20. Emamgholipour S., Hossein-Nezhad A., Sahraian M.A., Askarisadr F., Ansari M. Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes. Life Sci. 2015, 15:34-41.
21. Meng Z., Li J., Zhao H., Liu H., Zhang G., Wang L., et al. Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1. Exp. Ther. Med. 2015, 10:525-530.
22. Wang Q., Peng Y., Chen S., Gou X., Hu B., Du J., et al. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009, 40:2157-2164.
23. Garcia J.H., Wagner S., Liu K.F., Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stat. Validation Stroke. 1995, 26:627-634. (discussion 35).
24. Chen C., Hu Q., Yan J., Yang X., Shi X., Lei J., et al. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol. Dis. 2009, 33:509-517.
25. Liu H., Zhang X., Du Y., Ji H., Li S., Li L., et al. Leonurine protects brain injury by increased activities of UCP4, SOD, CAT and Bcl-2, decreased levels of MDA and Bax, and ameliorated ultrastructure of mitochondria in experimental stroke. Brain Res. 2012, 1474:73-81.
26. Eady T.N., Khoutorova L., Obenaus A., Mohd-Yusof A., Bazan N.G., Belayev L. Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats. Neurobiol. Dis. 2014, 62:1-7.
27. Choi Y.K., Cho G.S., Hwang S., Kim B.W., Lim J.H., Lee J.C., et al. Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation. Free Radic. Res. 2010, 44:925-935.
28. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97.
29. Niizuma K., Endo H., Chan P.H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem. 2009, 109(Suppl. 1):133-138.
30. Deb P., Sharma S., Hassan K.M. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 2010, 17:197-218.
31. Minami M., Katayama T., Satoh M. Brain cytokines and chemokines: roles in ischemic injury and pain. J. Pharmacol. Sci. 2006, 100:461-470.
32. Feng Y., Zhang Z., Li Q., Li W., Xu J., Cao H. Hyperbaric oxygen preconditioning protects lung against hyperoxic acute lung injury in rats via heme oxygenase-1 induction. Biochem. Biophys. Res. Commun. 2015, 456:549-554.
33. Huang G., Xu J., Xu L., Wang S., Li R., Liu K., et al. Hyperbaric oxygen preconditioning induces tolerance against oxidative injury and oxygen-glucose deprivation by up-regulating heat shock protein 32 in rat spinal neurons. PLoS One 2014, 9:e85967.
34. Yang L., Tang J., Chen Q., Jiang B., Zhang B., Tao Y., et al. Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics. Brain Res. 2015, 1627:21-30.
35. Li Y., Dong H., Chen M., Liu J., Yang L., Chen S., et al. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial. J. Cardiothorac. Vasc. Anesth. 2011, 25:908-916.
36. Wang Y.C., Zhang S., Du T.Y., Wang B., Sun X.Q. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by stimulating autophagy in neurocyte. Brain Res. 2010, 1323:149-151.
37. Qiang L., Lin H.V., Kim-Muller J.Y., Welch C.L., Gu W., Accili D. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab. 2011, 14:758-767.
38. Tsai K.L., Cheng Y.Y., Leu H.B., Lee Y.Y., Chen T.J., Liu D.H., et al. Investigating the role of Sirt1-modulated oxidative stress in relation to benign paroxysmal positional vertigo and Parkinson's disease. Neurobiol. Aging 2015, 36:2607-2616.
39. Gao J., Wang W.Y., Mao Y.W., Graff J., Guan J.S., Pan L., et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466:1105-1109.
40. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
41. Conti V., Forte M., Corbi G., Russomanno G., Formisano L., Landolfi A., et al. Sirtuins: a possible clinical implication in cardio- and cerebro-vascular systems. Curr. Drug Targets 2015.
42. Kumar R., Chaterjee P., Sharma P.K., Singh A.K., Gupta A., Gill K., et al. Sirtuin1: a promising serum protein marker for early detection of Alzheimer's disease. PLoS One 2013, 8:e61560.
43. Emamgholipour S., Hossein-Nezhad A., Sahraian M.A., Askarisadr F., Ansari M. Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes. Life Sci. 2016, 145:34-41.
44. Wan D., Zhou Y., Wang K., Hou Y., Hou R., Ye X. Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Res. Bull. 2016, 121:255-262.
45. Voghel G., Thorin-Trescases N., Farhat N., Nguyen A., Villeneuve L., Mamarbachi A.M., et al. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech. Ageing Dev. 2007, 128:662-671.
46. Mattagajasingh I., Kim C.S., Naqvi A., Yamamori T., Hoffman T.A., Jung S.B., et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14855-14860.
47. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2011, 14:593-605.
48. Wu J., Li Q., Wang X., Yu S., Li L., Wu X., et al. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 2013, 8:e59843.
49. Ren J., Fan C., Chen N., Huang J., Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res. 2011, 36:2352-2362.
50. Fujita K., Maeda D., Xiao Q., Srinivasula S.M. Nrf2-mediated induction of p62 controls Toll-like receptor-4-driven aggresome-like induced structure formation and autophagic degradation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1427-1432.
51. Wang B., Cao W., Biswal S., Dore S. Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 2011, 42:2605-2610.
52. Li L., Zhang X., Cui L., Wang L., Liu H., Ji H., et al. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res. 2013, 1497:32-39.
53. Cho B.O., Ryu H.W., Jin C.H., Choi D.S., Kang S.Y., Kim D.S., et al. Blackberry extract attenuates oxidative stress through up-regulation of Nrf2-dependent antioxidant enzymes in carbon tetrachloride-treated rats. J. Agric. Food Chem. 2011, 59:11442-11448.
54. Shah Z.A., Li R.C., Thimmulappa R.K., Kensler T.W., Yamamoto M., Biswal S., et al. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience 2007, 147:53-59.
55. Tamaki N., Cristina Orihuela-Campos R., Inagaki Y., Fukui M., Nagata T., Ito H.O. Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model. Free Radic. Biol. Med. 2014, 75:222-229.
56. Huang K., Huang J., Xie X., Wang S., Chen C., Shen X., et al. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-beta1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Free Radic. Biol. Med. 2013, 65:528-540.
57. Huang K., Chen C., Hao J., Huang J., Wang S., Liu P., et al. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-beta1 in rat glomerular messangial cells. Mol. Cell. Endocrinol. 2015, 399:178-189.
58. Canto C., Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 2009, 20:98-105.
59. Rodgers J.T., Lerin C., Gerhart-Hines Z., Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 2008, 582:46-53.
60. Do M.T., Kim H.G., Choi J.H., Jeong H.G. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1alpha/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radic. Biol. Med. 2014, 74:21-34.
61. Kulkarni S.R., Donepudi A.C., Xu J., Wei W., Cheng Q.C., Driscoll M.V., et al. Fasting induces nuclear factor E2-related factor 2 and ATP-binding Cassette transporters via protein kinase A and Sirtuin-1 in mouse and human. Antioxid. Redox Signal. 2014, 20:15-30.
62. Li J., Liu W., Ding S., Xu W., Guan Y., Zhang J.H., et al. Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res. 2008, 1210:223-229.
63. Zeng Y., Xie K., Dong H., Zhang H., Wang F., Li Y., et al. Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma. Brain Res. 2012, 1452:140-150.
64. Kawai Y., Garduno L., Theodore M., Yang J., Arinze I.J. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J. Biol. Chem. 2011, 286:7629-7640.
65. Hernandez-Jimenez M., Hurtado O., Cuartero M.I., Ballesteros I., Moraga A., Pradillo J.M., et al. Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 2013, 44:2333-2337.